Imo, if the FDA approves BTD, the BLA will be completed by the end of October, which is 5 weeks. NP cannot speak about it now because it is decided by the FDA and cannot create expectations and put pressure on the FDA. After pre-clinical testing, the FDA immediately approves Phase II for Leronlimab, they obviously respect Leronlimab and easily possibly give it BTD, which it absolutely has grounds for. By then the NP will be collecting money a little, it is 5-6 weeks.